{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:46:16Z","timestamp":1783647976108,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s12149-020-01570-8","type":"journal-article","created":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T10:12:22Z","timestamp":1609841542000},"page":"270-277","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Somatostatin receptor-positive breast lesions on 68Ga-DOTATATE PET\/CT"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6945-2003","authenticated-orcid":false,"given":"Duygu","family":"Has Simsek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine Goknur","family":"Isik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muge Nur","family":"Engin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serkan","family":"Kuyumcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayse","family":"Mudun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"Sanli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,5]]},"reference":[{"key":"1570_CR1","doi-asserted-by":"publisher","first-page":"855","DOI":"10.2967\/jnumed.112.114165","volume":"54","author":"RC Walker","year":"2013","unstructured":"Walker RC, Smith GT, Liu E, Moore B, Clanton J, Stabin M. Measured human dosimetry of 68Ga-DOTATATE. J Nucl Med. 2013;54:855\u201360.","journal-title":"J Nucl Med"},{"key":"1570_CR2","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1097\/RLU.0000000000002276","volume":"43","author":"S Singh","year":"2018","unstructured":"Singh S, Poon R, Wong R, Metser U. 68Ga PET imaging in patients with neuroendocrine tumors: a systematic review and meta-analysis. Clin Nucl Med. 2018;43:802\u201310.","journal-title":"Clin Nucl Med"},{"key":"1570_CR3","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2967\/jnumed.118.211706","volume":"60","author":"S Han","year":"2019","unstructured":"Han S, Suh CH, Woo S, Kim YJ, Lee JJ. Performance of 68Ga-DOTA\u2013Conjugated somatostatin receptor\u2013targeting peptide PET in detection of pheochromocytoma and paraganglioma: a systematic review and metaanalysis. J Nucl Med. 2019;60:369\u201376.","journal-title":"J Nucl Med"},{"key":"1570_CR4","doi-asserted-by":"publisher","first-page":"e14769","DOI":"10.1097\/MD.0000000000014769","volume":"98","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, Hou G, Cheng W. The utility of 18F-FDG and 68Ga-DOTA-Peptide PET\/CT in the evaluation of primary pulmonary carcinoid: a systematic review and meta-analysis. Medicine. 2019;98:e14769.","journal-title":"Medicine"},{"key":"1570_CR5","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1007\/s00259-006-0317-x","volume":"34","author":"P Antunes","year":"2007","unstructured":"Antunes P, Ginj M, Zhang H, Waser B, Baum R, Reubi J-C, et al. Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals? Eur J Nucl Med Mol Imaging. 2007;34:982\u201393.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1570_CR6","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s12149-013-0718-4","volume":"27","author":"S Kuyumcu","year":"2013","unstructured":"Kuyumcu S, \u00d6zkan ZG, Sanli Y, Yilmaz E, Mudun A, Adalet I, et al. Physiological and tumoral uptake of 68 Ga-DOTATATE: standardized uptake values and challenges in interpretation. Ann Nucl Med. 2013;27:538\u201345.","journal-title":"Ann Nucl Med"},{"key":"1570_CR7","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1148\/rg.352140164","volume":"35","author":"MS Hofman","year":"2015","unstructured":"Hofman MS, Lau WE, Hicks RJ. Somatostatin receptor imaging with 68Ga DOTATATE PET\/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation. Radiographics. 2015;35:500\u201316.","journal-title":"Radiographics"},{"key":"1570_CR8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.4274\/mirt.93064","volume":"25","author":"DH \u015eim\u015fek","year":"2016","unstructured":"\u015eim\u015fek DH, Kuyumcu S, Bilgi\u00e7 B, I\u015f\u0131k EG, T\u00fcrkmen C, Adalet I. An incidental solitary plasmacytoma of bone mimicking neuroendocrine tumor metastasis on 68Ga-DOTATATE positron emission tomography\/computed tomography. Mol Imaging Radionucl Ther. 2016;25:147.","journal-title":"Mol Imaging Radionucl Ther"},{"key":"1570_CR9","doi-asserted-by":"publisher","first-page":"e313","DOI":"10.1097\/RLU.0000000000001620","volume":"42","author":"LYI Yamaga","year":"2017","unstructured":"Yamaga LYI, Wagner J, De Gusmao Funari MB. 68Ga-DOTATATE PET\/CT in nonneuroendocrine tumors: a pictorial essay. Clin Nucl Med. 2017;42:e313\u20136.","journal-title":"Clin Nucl Med"},{"key":"1570_CR10","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1245\/s10434-010-0950-2","volume":"17","author":"A Chung","year":"2010","unstructured":"Chung A, Schoder H, Sampson M, Morrow M, Port E. Incidental breast lesions identified by 18F-fluorodeoxyglucose-positron emission tomography. Ann Surg Oncol. 2010;17:2119\u201325.","journal-title":"Ann Surg Oncol"},{"key":"1570_CR11","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2214\/AJR.10.6126","volume":"197","author":"BJ Kang","year":"2011","unstructured":"Kang BJ, Lee JH, Yoo IR, Kim SH, Choi JJ, Jeong SH, et al. Clinical significance of incidental finding of focal activity in the breast at 18F-FDG PET\/CT. Am J Roentgenol. 2011;197:341\u20137.","journal-title":"Am J Roentgenol"},{"key":"1570_CR12","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1007\/s00259-009-1147-4","volume":"36","author":"D Litmanovich","year":"2009","unstructured":"Litmanovich D, Gourevich K, Israel O, Gallimidi Z. Unexpected foci of 18 F-FDG uptake in the breast detected by PET\/CT: incidence and clinical significance. Eur J Nucl Med Mol imaging. 2009;36:1558\u201364.","journal-title":"Eur J Nucl Med Mol imaging"},{"key":"1570_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s41824-019-0063-5","volume":"3","author":"EM Aarstad","year":"2019","unstructured":"Aarstad EM, Nordhaug P, Naghavi-Behzad M, Larsen LB, Gerke O, Hildebrandt MG. Prevalence of focal incidental breast uptake on FDG-PET\/CT and risk of malignancy: a systematic review and meta-analysis. Eur J Hybrid Imaging. 2019;3:16.","journal-title":"Eur J Hybrid Imaging"},{"key":"1570_CR14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3413\/nukmed-0185","volume":"47","author":"F Elgeti","year":"2008","unstructured":"Elgeti F, Amthauer H, Denecke T, Steffen I, Heuck F, Stelter L, et al. Incidental detection of breast cancer by 68Ga-DOTATOC-PET\/CT in women suffering from neuroendocrine tumours. Nuklearmedizin. 2008;47:261\u20135.","journal-title":"Nuklearmedizin"},{"key":"1570_CR15","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/RLU.0000000000001463","volume":"42","author":"GZ Papadakis","year":"2017","unstructured":"Papadakis GZ, Millo C, Sadowski SM, Karantanas AH, Bagci U, Patronas NJ. Breast fibroadenoma with increased activity on 68Ga-DOTATATE PET\/CT. Clin Nucl Med. 2017;42:145.","journal-title":"Clin Nucl Med"},{"key":"1570_CR16","doi-asserted-by":"publisher","first-page":"e11878","DOI":"10.1097\/MD.0000000000011878","volume":"97","author":"TS Vieira","year":"2018","unstructured":"Vieira TS, Faria DB, Moura CS, Francisco E, Barroso S, de Oliveira JP. Incidental finding of a breast carcinoma on Ga-68-DOTA-1-Nal3-octreotide positron emission tomography\/computed tomography performed for the evaluation of a pancreatic neuroendocrine tumor: a case report. Medicine. 2018;97:e11878.","journal-title":"Medicine."},{"key":"1570_CR17","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.2967\/jnumed.114.142224","volume":"55","author":"DH Simsek","year":"2014","unstructured":"Simsek DH, Kuyumcu S, Turkmen C, Sanl\u0131 Y, Aykan F, Unal S, et al. Can complementary 68Ga-DOTATATE and 18F-FDG PET\/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors? J Nucl Med. 2014;55:1811\u20137.","journal-title":"J Nucl Med"},{"key":"1570_CR18","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/ijc.2910430302","volume":"43","author":"M Papotti","year":"1989","unstructured":"Papotti M, Macri L, Bussolati G, Reubi J. Correlative study on neuro-endocrine differentiation and presence of somatostatin receptors in breast carcinomas. Int J Cancer. 1989;43:365\u20139.","journal-title":"Int J Cancer"},{"key":"1570_CR19","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1002\/1097-0142(19890915)64:6<1254::AID-CNCR2820640615>3.0.CO;2-D","volume":"64","author":"JC Reubi","year":"1989","unstructured":"Reubi JC, Torhorst J. The relationship between somatostatin, epidermal growth factor, and steroid hormone receptors in breast cancer. Cancer. 1989;64:1254\u201360.","journal-title":"Cancer"},{"key":"1570_CR20","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/ijc.2910460315","volume":"46","author":"J Reubi","year":"1990","unstructured":"Reubi J, Waser B, Foekens J, Klijn J, Lamberts S, Laissue J. Somatostatin receptor incidence and distribution in breast cancer using receptor autoradiography: relationship to EGF receptors. Int J Cancer. 1990;46:416\u201320.","journal-title":"Int J Cancer"},{"key":"1570_CR21","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1677\/erc.0.0110323","volume":"11","author":"C Orlando","year":"2004","unstructured":"Orlando C, Raggi CC, Bianchi S, Distante V, Simi L, Vezzosi V, et al. Measurement of somatostatin receptor subtype 2 mRNA in breast cancer and corresponding normal tissue. Endocr Relat Cancer. 2004;11:323\u201332.","journal-title":"Endocr Relat Cancer"},{"key":"1570_CR22","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/S0140-6736(94)92637-9","volume":"343","author":"C Van Eijck","year":"1994","unstructured":"Van Eijck C, Jeekel J, Krenning E, Bootsma A, Lamberts S, Oei H, et al. Somatostatin-receptor scintigraphy in primary breast cancer. Lancet. 1994;343:640\u20133.","journal-title":"Lancet"},{"key":"1570_CR23","first-page":"622","volume":"37","author":"M Bajc","year":"1996","unstructured":"Bajc M, Ingvar C, Palmer J. Dynamic indium-111-pentetreotide scintigraphy in breast cancer. J Nucl Med. 1996;37:622\u20136.","journal-title":"J Nucl Med"},{"key":"1570_CR24","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1007\/BF00181765","volume":"20","author":"E Krenning","year":"1993","unstructured":"Krenning E, Kwekkeboom DJ, Bakker W, Breeman W, Kooij P, Oei H, et al. Somatostatin receptor scintigraphy with [111 In-DTPA-D-Phe 1]-and [123 I-Tyr 3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med. 1993;20:716\u201331.","journal-title":"Eur J Nucl Med"},{"key":"1570_CR25","first-page":"325","volume":"16","author":"U Goehring","year":"1993","unstructured":"Goehring U, Scheidhauer K, Schom\u00e4cker K, Scharl A. In-vivo-receptor scintigraphy with 111 In-octreotid in patients with breast tumors. Nuklearmediziner. 1993;16:325\u201330.","journal-title":"Nuklearmediziner"},{"key":"1570_CR26","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.nucmedbio.2008.04.010","volume":"35","author":"F Wang","year":"2008","unstructured":"Wang F, Wang Z, Wu J, Qu W, Yao W, Zhao J, et al. The role of technetium-99m-labeled octreotide acetate scintigraphy in suspected breast cancer and correlates with expression of SSTR. Nucl Med Biol. 2008;35:665\u201371.","journal-title":"Nucl Med Biol"},{"key":"1570_CR27","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/BF01081525","volume":"22","author":"B Meunier","year":"1995","unstructured":"Meunier B, Le Cloire J, Dazord L, Leveque J, Lesimple T, Tas P, et al. Per operative localization of a carcinoid tumour of the breast using indium-111 pentetreotide and a nuclear surgical probe. Eur J Nucl Med. 1995;22:281\u20133.","journal-title":"Eur J Nucl Med"},{"key":"1570_CR28","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S0960-9776(97)90699-8","volume":"6","author":"A Chili","year":"1997","unstructured":"Chili A, Agresti R, Savelli G, Giovanazzi R, Greco M, Bombardieri E. Radionuclide imaging of unexpected multifocal breast cancer: surgical implications. Breast. 1997;6:386\u20137.","journal-title":"Breast"},{"key":"1570_CR29","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1002\/1097-0142(20011101)92:9<2259::AID-CNCR1571>3.0.CO;2-O","volume":"92","author":"SN Georgiannos","year":"2001","unstructured":"Georgiannos SN, Chin Aleong J, Goode AW, Sheaff M. Secondary neoplasms of the breast: a survey of the 20th Century. Cancer. 2001;92:2259\u201366.","journal-title":"Cancer"},{"key":"1570_CR30","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.2967\/jnumed.116.189035","volume":"58","author":"SU Dalm","year":"2017","unstructured":"Dalm SU, Haeck J, Doeswijk GN, de Blois E, de Jong M, van Deurzen CH. SSTR-mediated imaging in breast cancer: is there a role for radiolabeled somatostatin receptor antagonists? J Nucl Med. 2017;58:1609\u201314.","journal-title":"J Nucl Med"},{"key":"1570_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41181-017-0023-y","volume":"2","author":"I Dude","year":"2017","unstructured":"Dude I, Zhang Z, Rousseau J, Hundal-Jabal N, Colpo N, Merkens H, et al. Evaluation of agonist and antagonist radioligands for somatostatin receptor imaging of breast cancer using positron emission tomography. EJNMMI Radiopharm Chem. 2017;2:1\u201316.","journal-title":"EJNMMI Radiopharm Chem"},{"key":"1570_CR32","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1259\/bjr\/58729988","volume":"83","author":"P Moyle","year":"2010","unstructured":"Moyle P, Sonoda L, Britton P, Sinnatamby R. Incidental breast lesions detected on CT: what is their significance? Br J Radiol. 2010;83:233\u201340.","journal-title":"Br J Radiol"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-020-01570-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-020-01570-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-020-01570-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T21:46:43Z","timestamp":1613771203000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-020-01570-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,5]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["1570"],"URL":"https:\/\/doi.org\/10.1007\/s12149-020-01570-8","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,5]]},"assertion":[{"value":"1 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no financial or personal relationships with other people or organizations that could inappropriately influence this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}